NELLIX
Nellix has developed an original device designed to address and expand the indication for the less invasive treatment of Abdominal Aortic Aneurysms (AAAs) and Thoratic Aortic Aneurysms (TAAs). Enabling the treatment of all aneurysms with a low profiles delivery system and innovative endograft, the Nellix device has the potential to double the market size for Endovascular Aneurysms Repair (EVAR), which exceeded $800M in 2008 with a 16% CAGR (Med Tech Insight).
NELLIX
Industry:
Health Care Medical Device
Founded:
2001-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.nellix.com
Total Employee:
11+
Status:
Closed
Contact:
650-213-8700
Email Addresses:
[email protected]
Total Funding:
8.76 M USD
Similar Organizations
Curon Medical
Curon Medical manufactures devices for the minimally invasive treatment of gastrointestinal diseases.
EndoMetabolic Solutions
EndoMetabolic Solutions develops a medical device for the surgical treatment of obesity.
Osseon Therapeutics
Osseon Therapeutics develops medical devices for minimally-invasive treatments of degenerative bone and joint diseases.
Investors List
Incept BioSystems
Incept BioSystems investment in Series C - Nellix
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Series C - Nellix
Incubic Venture Fund
Incubic Venture Fund investment in Series B - Nellix
